Non-obesogenic doses of fatty acids modulate the functionality of the circadian clock in the liver.
ARNTL Transcription Factors
/ metabolism
Animals
CLOCK Proteins
/ metabolism
Cell Line
Circadian Clocks
/ physiology
Circadian Rhythm
/ drug effects
Fatty Acids, Unsaturated
/ biosynthesis
Liver
/ physiology
Male
Mice
Mice, Inbred C57BL
Oleic Acid
/ pharmacology
Olive Oil
/ pharmacology
Oxidation-Reduction
/ drug effects
Palm Oil
/ pharmacology
Palmitates
/ pharmacology
Transcriptional Activation
/ drug effects
Circadian
Clock
Hepatocyte
Liver
Metabolism
Oleate
Palmitate
Journal
Cellular and molecular life sciences : CMLS
ISSN: 1420-9071
Titre abrégé: Cell Mol Life Sci
Pays: Switzerland
ID NLM: 9705402
Informations de publication
Date de publication:
May 2019
May 2019
Historique:
received:
24
10
2018
accepted:
22
01
2019
revised:
01
01
2019
pubmed:
30
1
2019
medline:
2
5
2019
entrez:
30
1
2019
Statut:
ppublish
Résumé
Saturated fatty acids, such as palmitate, lead to circadian disruption in cell culture. Moreover, information regarding the effects of unsaturated fatty acids on circadian parameters is scarce. We aimed at studying the effects of low doses of saturated as well as unsaturated fatty acids on circadian metabolism in vivo and at deciphering the mechanism by which fatty acids convey their effect. Mice were fed non-obesogenic doses of palm or olive oil and hepatocytes were treated with palmitate and oleate. Mice fed non-obesogenic doses of palm oil showed increased signaling towards fatty acid synthesis, while olive oil increased signaling towards fatty acid oxidation. Low doses of palmitate and oleate were sufficient to alter circadian rhythms, due to changes in the expression and/or activity of key metabolic proteins. Palmitate, but not oleate, counteracted the reduction in lipid accumulation and BMAL1-induced expression of mitochondrial genes involved in fatty acid oxidation. Palmitate was also found to interfere with the transcriptional activity of CLOCK:BMAL1 by preventing BMAL1 deacetylation and activation. In addition, palmitate, but not oleate, reduced PER2-mediated transcriptional activation and increased REV-ERBα-mediated transcriptional inhibition of Bmal1. The inhibition of PER2-mediated transcriptional activation by palmitate was achieved by interfering with PER2 nuclear translocation. Indeed, PER2 reduced fat accumulation in hepatocytes and this reduction was prevented by palmitate. Herein, we show that the detrimental metabolic alteration seen with high doses of palmitate manifests itself early on even with non-obesogenic levels. This is achieved by modulating BMAL1 at several levels abrogating its activity and expression.
Identifiants
pubmed: 30694347
doi: 10.1007/s00018-019-03023-6
pii: 10.1007/s00018-019-03023-6
doi:
Substances chimiques
ARNTL Transcription Factors
0
Bmal1 protein, mouse
0
Fatty Acids, Unsaturated
0
Olive Oil
0
Palmitates
0
Oleic Acid
2UMI9U37CP
Palm Oil
5QUO05548Z
CLOCK Proteins
EC 2.3.1.48
Clock protein, mouse
EC 2.3.1.48
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1795-1806Références
Cell. 2001 Dec 28;107(7):855-67
pubmed: 11779462
Curr Biol. 2002 Jan 22;12(2):147-52
pubmed: 11818067
Cell. 2002 May 3;109(3):307-20
pubmed: 12015981
Cell. 2002 Jul 26;110(2):251-60
pubmed: 12150932
Nature. 2002 Aug 1;418(6897):534-9
pubmed: 12152080
Nature. 2002 Aug 29;418(6901):935-41
pubmed: 12198538
Proc Natl Acad Sci U S A. 2003 Mar 18;100(6):3077-82
pubmed: 12629214
J Biol Rhythms. 2003 Jun;18(3):250-60
pubmed: 12828282
Neuron. 2004 Aug 19;43(4):527-37
pubmed: 15312651
Biochem J. 2005 Mar 15;386(Pt 3):575-81
pubmed: 15500444
Cell. 2004 Nov 24;119(5):693-705
pubmed: 15550250
Mol Cell Biol. 2005 Apr;25(7):2795-807
pubmed: 15767683
J Atheroscler Thromb. 2005;12(3):169-74
pubmed: 16020918
Mol Endocrinol. 2006 Aug;20(8):1715-27
pubmed: 16556735
Diabetes. 2006 Apr;55(4):962-70
pubmed: 16567517
Antioxid Redox Signal. 2006 Jul-Aug;8(7-8):1339-49
pubmed: 16910781
Chronobiol Int. 2006;23(5):905-14
pubmed: 17050208
Nature. 2007 May 24;447(7143):477-81
pubmed: 17476214
J Biol Chem. 2007 Jul 20;282(29):20794-8
pubmed: 17525164
Cell Metab. 2007 Nov;6(5):414-21
pubmed: 17983587
Nature. 2007 Dec 13;450(7172):1086-90
pubmed: 18075593
Mol Immunol. 2008 Jun;45(11):3163-7
pubmed: 18433872
Cell. 2008 Jul 25;134(2):317-28
pubmed: 18662546
Cell. 2008 Jul 25;134(2):329-40
pubmed: 18662547
Endocrinology. 2009 Jan;150(1):161-8
pubmed: 18801899
Science. 2009 May 1;324(5927):654-7
pubmed: 19286518
Obesity (Silver Spring). 2010 Feb;18(2):230-8
pubmed: 19713948
Science. 2009 Oct 16;326(5951):437-40
pubmed: 19833968
Int J Obes (Lond). 2010 Feb;34(2):227-39
pubmed: 19901953
Genes Dev. 2010 Feb 15;24(4):345-57
pubmed: 20159955
J Cell Mol Med. 2011 Dec;15(12):2745-59
pubmed: 20731750
J Hepatol. 2011 Apr;54(4):765-72
pubmed: 21147505
Biochem Biophys Res Commun. 2011 Sep 30;413(3):414-9
pubmed: 21893042
Cell. 2013 Dec 19;155(7):1464-78
pubmed: 24360271
Cell Rep. 2014 May 22;7(4):1056-64
pubmed: 24794436
Am J Physiol Regul Integr Comp Physiol. 2014 Oct 15;307(8):R1049-60
pubmed: 25144192
Biochim Biophys Acta. 2015 Aug;1851(8):1017-25
pubmed: 25483623
J Biol Chem. 2015 Feb 13;290(7):4367-82
pubmed: 25544291
Cell. 2015 May 21;161(5):1138-1151
pubmed: 25981667
PLoS One. 2015 Jun 15;10(6):e0130047
pubmed: 26075729
Cell Metab. 2015 Oct 6;22(4):709-20
pubmed: 26365180
Endocrinology. 2016 Feb;157(2):586-99
pubmed: 26646204
EBioMedicine. 2016 May;7:100-11
pubmed: 27322464
Endocr Rev. 2018 Jun 1;39(3):261-273
pubmed: 29490014
J Cell Biol. 1985 Mar;100(3):965-73
pubmed: 3972906
J Biol Chem. 1993 Aug 5;268(22):16265-9
pubmed: 8344913